FdaApplication

ANDA 209389

Back to search

Identifiers

Properties

PropertyValue
applicant_nameIPCA LABORATORIES LTD
application_typeANDA
approval_date2023-10-30

Products (2)

ProductActive ingredientStrengthDosage form
ONDANSETRONONDANSETRON4MGTABLET, ORALLY DISINTEGRATING;ORAL
ONDANSETRONONDANSETRON8MGTABLET, ORALLY DISINTEGRATING;ORAL

2 products